nadofaragene firadenovec-vncg
Term · Oncology and biomedicine · MLC-T-ONC-015406
A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, nadofaragene firadenovec-vncg infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.
| Identifier | MLC-T-ONC-015406 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rAd-IFN |
| Synonyms | recombinant adenovirus-interferon SCH 721015; nadofaragene firadenovec; nadofaragene firadenovec/Syn3; recombinant adenovirus-interferon with Syn3; recombinant adenovirus-interferon/Syn3 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015406",
"term": "nadofaragene firadenovec-vncg",
"field": "Oncology and biomedicine",
"definition": "A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, nadofaragene firadenovec-vncg infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.",
"abbreviation": "rAd-IFN",
"synonyms": [
"recombinant adenovirus-interferon SCH 721015",
"nadofaragene firadenovec",
"nadofaragene firadenovec/Syn3",
"recombinant adenovirus-interferon with Syn3",
"recombinant adenovirus-interferon/Syn3"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nadofaragene-firadenovec-vncg/"
}
Record 11,551 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.